Vimarsana
Biggest News Aggregation in the World

Mindscape Ketamine News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mindscape Ketamine. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mindscape Ketamine Today - Breaking & Trending Today

Wellbeing Digital Sciences Inc reports revenue of C$5.28M in nine months ended April 30, 2022 - Vimarsana News

Wellbeing Digital Sciences Inc reports revenue of C$5.28M in nine months ended April 30, 2022

Wellbeing Digital Sciences (NEO:MEDI.AQN, OTCQB:KONEF) Inc said its revenue in the nine months ending April 30, 2022, came in at C$5,280,640 from nil in the...

MindScape Ketamine & Infusion Therapy Is Seeking Patients For A Depression-Focused Clinical Study - Vimarsana News

MindScape Ketamine & Infusion Therapy Is Seeking Patients For A Depression-Focused Clinical Study

Houston, May 25, 2022 (GLOBE NEWSWIRE) -- Houston, Texas - MindScape Ketamine & Infusion Therapy from Houston, ...

MindScape Ketamine & Infusion Therapy Currently Screening - Vimarsana News

MindScape Ketamine & Infusion Therapy Currently Screening

Houston, April 13, 2022 (GLOBE NEWSWIRE) -- Houston, Texas - MindScape Ketamine & Infusion Therapy, PLLC, a ketamine therapy clinic in Houston,...

MindScape Ketamine & Infusion Therapy Is Offering - Vimarsana News

MindScape Ketamine & Infusion Therapy Is Offering

Houston, March 24, 2022 (GLOBE NEWSWIRE) -- Houston, Texas - MindScape Ketamine & Infusion Therapy is bringing the benefits of IV Ketamine...

Myconic Capital Announces Closing of Mindscape Ketamine & Infusions Therapy Acquisition - Vimarsana News

Myconic Capital Announces Closing of Mindscape Ketamine & Infusions Therapy Acquisition

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Myconic Capital Announces Closing of Mindscape Ketamine & Infusions Therapy Acquisition MYCONIC CAPITAL CORP.April 22, 2021 GMT VANCOUVER, British Columbia, April 21, 2021 (GLOBE NEWSWIRE) -- Myconic Capital Corp. (formerly, Auralite Investments Inc.) (CSE: MEDI) (FRA: MY0) (the “Company” or “Myconic”) is pleased to announce that, further to its press release of March 10, 2021, it has completed the acquisition of all of the issued and outstanding equity of Mindscape Ketamine & Infusions Ther...

Source: apnews.com